drugset / Trial / NCT04015648
Safety and Immunogenicity of a Candidate ZIKV Vaccine (ZIKA001)
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is a FIH, open-label, dose escalation, phase I clinical trial to assess the safety and immunogenicity of the candidate ChAdOx1 Zika vaccine in healthy volunteers administered intramuscularly.
Timeline
- Start
- 2019-10-21
- Primary completion
- 2022-03-10
- Completion
- 2022-03-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ChAdOx1 Zika | Vaccine | 5e+09 unknown | Intramuscular |
| Subject | ChAdOx1 Zika | Vaccine | 2.5e+10 unknown | Intramuscular |
| Subject | ChAdOx1 Zika | Vaccine | 5e+10 unknown | Intramuscular |